BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 61 filers reported holding BEAM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,020,911 | -18.7% | 541,410 | +8.0% | 0.00% | -20.0% |
Q2 2023 | $16,010,341 | +12.8% | 501,420 | +8.2% | 0.01% | +25.0% |
Q1 2023 | $14,195,861 | -21.3% | 463,614 | +0.5% | 0.00% | -33.3% |
Q4 2022 | $18,035,733 | -16.2% | 461,154 | +2.0% | 0.01% | -25.0% |
Q3 2022 | $21,529,000 | +39.9% | 451,907 | +13.7% | 0.01% | +60.0% |
Q2 2022 | $15,386,000 | -27.6% | 397,449 | +7.2% | 0.01% | -16.7% |
Q1 2022 | $21,254,000 | -23.3% | 370,916 | +6.6% | 0.01% | -25.0% |
Q4 2021 | $27,719,000 | -4.5% | 347,824 | +4.3% | 0.01% | -11.1% |
Q3 2021 | $29,020,000 | -10.3% | 333,520 | +32.6% | 0.01% | -18.2% |
Q2 2021 | $32,363,000 | +84.0% | 251,442 | +14.5% | 0.01% | +83.3% |
Q1 2021 | $17,585,000 | +5.7% | 219,692 | +7.9% | 0.01% | -14.3% |
Q4 2020 | $16,629,000 | +293.8% | 203,682 | +18.8% | 0.01% | +250.0% |
Q3 2020 | $4,223,000 | +82.6% | 171,511 | +107.6% | 0.00% | +100.0% |
Q2 2020 | $2,313,000 | +393.2% | 82,602 | +217.6% | 0.00% | – |
Q1 2020 | $469,000 | – | 26,005 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |